Document detail
ID

oai:pubmedcentral.nih.gov:1059...

Topic
Review
Author
Alshami, Issam Alattas, Raghad O Waad A, Alofi Anwar A, Sayed
Langue
en
Editor

Biomedical Informatics

Category

Bioinformation

Year

2023

listing date

11/28/2023

Keywords
cancer cervical
Metrics

Abstract

Cervical cancer is an important health problem and it is considered the fourth most lethal women's cancer worldwide.

The intertumoral T cell pool is exposed in a number of immunosuppressive pathways.

Therefore, it is of interest to document the effect of cervical cancer on immune system, the role of T cells in the development and pathogenesis of cervical cancer.

HPV is considered the most important risk factors for developing cervical cancer, HPV 16 and 18, the two most common oncogenic types which are high risk HPV cause 70% of cervical cancer cases.

In the cervical mucosa, the proportion of CD4+ and CD8+ T cells is related to the severity of the lesions.

Cervical cancer can be treated by immunotherapeutic vaccine which involves T cells.

T cells play an important part in cervical cancer pathogenesis because HPV exploits several methods to avoid host T-cell immune surveillance.

T-cell-based immunotherapy is important because it is selective and has therapeutic potential.

Alshami, Issam,Alattas, Raghad O,Waad A, Alofi,Anwar A, Sayed, 2023, Role of T cells in cervical cancer, Biomedical Informatics

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

Gene expression profiles in clinically T1-2N0 ER+HER2− breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
breast cancer sentinel lymph node biopsy gene expression profile adjuvant chemotherapy gep treated status guideline-2020 outcome patients cancer chemotherapy breast predict